C10 Pharma (Norway)

Recent papers from C10 Pharma (Norway)

1. In Vitro and In Vivo Efficacy of the Broad-Spectrum β-Lactamase Inhibitor APC24-7 in Combination with Meropenem Against Carbapenem-Resistant EnterobacteralesAntibiotics · 2026
2. A first‐in‐human study of CAL101, a monoclonal antibody targeting S100A4British Journal of Clinical Pharmacology · 2026
3. The epidemiology and societal costs of myasthenia gravis in Norway: A non‐interventional study using national registry dataEuropean Journal of Neurology · 2024
4. Pharmacokinetics of a novel, approved, 1.4‐mg intranasal naloxone formulation for reversal of opioid overdose—a randomized controlled trialAddiction · 2019
5. Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF‐2 domain of blood coagulation factor VIIJournal of Peptide Research · 2001
6. Beneficial Effects of a Soy-Based Dietary Supplement on Lipid Levels and Cardiovascular Risk Markers in Type 2 Diabetic SubjectsDiabetes Care · 2001
7. Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement TherapyThrombosis and Haemostasis · 2000
8. Monocyte Procoagulant Activity Induced by Adherence to an Artificial Surface Is Reduced by End-point Immobilized Heparin-coating of the SurfaceThrombosis and Haemostasis · 1998
9. INTRACELLULAR LOCALIZATION OF SULFONATED meso‐TETRAPHENYLPORPHINES IN A HUMAN CARCINOMA CELL LINE*Photochemistry and Photobiology · 1990